全文获取类型
收费全文 | 2463篇 |
免费 | 8篇 |
专业分类
电工技术 | 12篇 |
化学工业 | 121篇 |
金属工艺 | 44篇 |
机械仪表 | 16篇 |
建筑科学 | 22篇 |
矿业工程 | 28篇 |
能源动力 | 1篇 |
轻工业 | 12篇 |
水利工程 | 15篇 |
石油天然气 | 68篇 |
无线电 | 28篇 |
一般工业技术 | 143篇 |
冶金工业 | 1849篇 |
原子能技术 | 51篇 |
自动化技术 | 61篇 |
出版年
2022年 | 14篇 |
2021年 | 12篇 |
2019年 | 9篇 |
2018年 | 26篇 |
2017年 | 23篇 |
2016年 | 19篇 |
2015年 | 8篇 |
2014年 | 23篇 |
2013年 | 17篇 |
2012年 | 21篇 |
2011年 | 20篇 |
2010年 | 23篇 |
2009年 | 18篇 |
2008年 | 9篇 |
2007年 | 20篇 |
2006年 | 16篇 |
2004年 | 10篇 |
2003年 | 26篇 |
2002年 | 12篇 |
2001年 | 9篇 |
2000年 | 11篇 |
1999年 | 75篇 |
1998年 | 604篇 |
1997年 | 310篇 |
1996年 | 215篇 |
1995年 | 128篇 |
1994年 | 109篇 |
1993年 | 108篇 |
1992年 | 10篇 |
1991年 | 20篇 |
1990年 | 32篇 |
1989年 | 23篇 |
1988年 | 35篇 |
1987年 | 23篇 |
1986年 | 24篇 |
1985年 | 13篇 |
1984年 | 13篇 |
1983年 | 10篇 |
1982年 | 21篇 |
1981年 | 18篇 |
1980年 | 21篇 |
1979年 | 11篇 |
1978年 | 15篇 |
1977年 | 57篇 |
1976年 | 103篇 |
1975年 | 19篇 |
1974年 | 14篇 |
1973年 | 13篇 |
1972年 | 15篇 |
1971年 | 13篇 |
排序方式: 共有2471条查询结果,搜索用时 15 毫秒
51.
Alexandra V. Dyomina Anna A. Kovalenko Maria V. Zakharova Tatiana Yu. Postnikova Alexandra V. Griflyuk Ilya V. Smolensky Irina V. Antonova Aleksey V. Zaitsev 《International journal of molecular sciences》2022,23(1)
Metabotropic glutamate receptors (mGluRs) are expressed predominantly on neurons and glial cells and are involved in the modulation of a wide range of signal transduction cascades. Therefore, different subtypes of mGluRs are considered a promising target for the treatment of various brain diseases. Previous studies have demonstrated the seizure-induced upregulation of mGluR5; however, its functional significance is still unclear. In the present study, we aimed to clarify the effect of treatment with the selective mGluR5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) on epileptogenesis and behavioral impairments in rats using the lithium–pilocarpine model. We found that the administration of MTEP during the latent phase of the model did not improve survival, prevent the development of epilepsy, or attenuate its manifestations in rats. However, MTEP treatment completely prevented neuronal loss and partially attenuated astrogliosis in the hippocampus. An increase in excitatory amino acid transporter 2 expression, which has been detected in treated rats, may prevent excitotoxicity and be a potential mechanism of neuroprotection. We also found that MTEP administration did not prevent the behavioral comorbidities such as depressive-like behavior, motor hyperactivity, reduction of exploratory behavior, and cognitive impairments typical in the lithium–pilocarpine model. Thus, despite the distinct neuroprotective effect, the MTEP treatment was ineffective in preventing epilepsy. 相似文献
52.
V. A. Kashirtsev E. Yu. Kovalenko R. S. Min T. A. Sagachenko 《Solid Fuel Chemistry》2009,43(4):197-200
The molecular composition of the S-, O-, and N-containing heterocyclic aromatic compounds of bitumen separated from the rocks of the Cambrian oil shale formation was studied. Among the sulfur compounds, dibenzothiophene, its alkyl and naphthene derivatives, naphthobenzothiophenes, and their alkyl homologs were identified. Among the oxygen compounds, unbranched dibenzo- and naphthobenzofuran and their C1–C4 and C1–C2 alkyl homologs, respectively, were detected. Acridinones, benzoacridinones, and their alkyl homologs were present among the nitrogen compounds. 相似文献
53.
M.N. Sviridenko V.K. Kapyshev V.G. Kovalenko S.A. Makarov A.Yu. Leshukov A.V. Razmerov Yu.S. Strebkov 《Fusion Engineering and Design》2009,84(1):9-14
The development of manufacturing technology for the ceramic helium-cooled test blanket module (CHC TBM) is performed in the framework of the concept for RF Federal government program to master the fusion nuclear energy and as a part of the development of DEMO blanket technology.The main technical approach to the development of CHC TBM manufacturing technology is to provide the “combined” analogy with design decisions of DEMO blanket structural elements.The manufacturing technology of CHC TBM structural elements (first wall cramp, load-bearing back cramp, tritium-breeding element and attachment system) has been proposed during the period of 2004-2007. The design details of TBM structural elements and critical issues of manufacturing technology development are also presented in this paper. 相似文献
54.
GL Clayman AK el-Naggar SM Lippman YC Henderson M Frederick JA Merritt LA Zumstein TM Timmons TJ Liu L Ginsberg JA Roth WK Hong P Bruso H Goepfert 《Canadian Metallurgical Quarterly》1998,16(6):2221-2232
PURPOSE: Standard therapies of head and neck squamous cell carcinoma (HNSCC) often cause profound morbidity and have not significantly improved survival over the last 30 years. Preclinical studies showed that adenoviral vector delivery of the wild-type p53 gene reduced tumor growth in mouse xenograft models. Our purpose was to ascertain the safety and therapeutic potential of adenoviral (Ad)-p53 in advanced HNSCC. PATIENTS AND METHODS: Patients with incurable recurrent local or regionally metastatic HNSCC received multiple intratumoral injections of Ad-p53, either with or without tumor resection. Patients were monitored for adverse events and antiadenoviral antibodies, tumors were monitored for response and p53 expression, and body fluids were analyzed for Ad-p53. RESULTS: Tumors of 33 patients were injected with doses of up to 1 x 10(11) plaque-forming units (pfu). No dose-limiting toxicity or serious adverse events were noted. p53 expression was detected in tumor biopsies despite antibody responses after Ad-p53 injections. Clinical efficacy could be evaluated in 17 patients with nonresectable tumors: two patients showed objective tumor regressions of greater than 50%, six patients showed stable disease for up to 3.5 months, and nine patients showed progressive disease. One resectable patient was considered a complete pathologic response. Ad-p53 was detected in blood and urine in a dose-dependent fashion, and in sputum. CONCLUSION: Patients were safely injected intratumorally with Ad-p53. Objective antitumor activity was detected in several patients. The infectious Ad-p53 in body fluids was asymptomatic, and suggests that systemic or regional treatment may be tolerable. These results suggest the further investigation of Ad-p53 as a therapeutic agent for patients with HNSCC. 相似文献
55.
56.
57.
58.
N Brouard A Chapel TM Neildez-Nguyen C Granotier I Khazaal B Péault D Thierry 《Canadian Metallurgical Quarterly》1998,12(7):1128-1135
The non-obese diabetic-severe combined immunodeficiency (NOD-SCID) mouse is a convenient host for human hematopoietic tissues and cells. Human fetal bone fragments engrafted subcutaneously in NOD-SCID mice sustain human hematopoiesis for several months. MS5 murine bone marrow stromal cells were transfected by electroporation with a plasmid containing the human interleukin-3 gene. As expected, stably transfected hu-IL3-MS5 cells supported human hematopoiesis in vitro more efficiently than MS5 cells. hu-IL3-MS5 cells were then injected intravenously into hu-NOD-SCID mice to test their ability to home to the mouse and/or human bone marrow, and to evaluate the role of hu-IL3 secretion on human hematopoiesis in vivo. hu-IL3 was detected in the mouse serum for up to an observation time of 8 weeks. hu-IL3-MS5 cells engrafted the bone marrow, spleen, liver and lungs of the mice but also the human bone graft. The presence of hu-IL3-MS5 cells in the human bone significantly stimulated local human hematopoiesis. This setting could be used to model the bone marrow homing of intravenously injected stromal cells or stromal cell precursors. The same experimental principle could also be applied in a therapeutic perspective to malignant human bone marrow hematopoiesis. 相似文献
59.
60.
TM Gerhardt GE Schmahl C Flotho AV Rath CM Niemeyer 《Canadian Metallurgical Quarterly》1997,99(4):882-887
Activation of the Evi-1 gene was first described to be associated with the transformation of murine myeloid leukaemias and has previously been detected in cases of human acute myeloid leukaemia (AML) and chronic myeloid leukaemia (CML) in blast crises and in myelodysplastic syndromes. In this study we determined the frequency and the level of Evi-1 expression in juvenile myelomonocytic leukaemia (JMML) and in normal haemopoiesis. Using RT-PCR and Southern blot hybridization mRNA of Evi-1 could be detected in bone marrow (BM) and peripheral blood (PB) mononuclear cells (MNC) of normal donors. In JMML 12/20 patients examined expressed elevated levels of Evi-1 compared to normal controls. In these samples over-expression of the gene was correlated with a higher percentage of blasts (P = 0.02). Expression levels in BFU-E and CFU-GM derived colonies from BM of JMML patients were lower than those in the corresponding MNC samples. Analysis of CD34+ and CD34- cells demonstrated that Evi-1 is primarily expressed in the CD34+ cell population of both JMML and normal donors. These findings suggest that Evi-1 expression is linked to the early stages of haemopoiesis. Studies on the regulation of Evi-1 expression in CD34+ cells will elucidate its function in progenitor cells and clarify its possible role in the pathogenesis of JMML. 相似文献